ITGA6 and plasma cell leukemia: ITGA6-AS1, as an antisense non-coding RNA of ITGA6, can specifically target ITGA6 and lead to its increased expression, thereby regulating the occurrence and aggressiveness of breast cancer and secondary plasmacytic leukaemia 23 (Figure 7B).